Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
The biopharma industry was pressured to get faster and more innovative to respond to the urgent global health challenge of the past year. Asian-American executives have played a key role in leading this charge, although they often aren’t in front of the cameras and microphones. As part of Asian American and Pacific Islander Heritage Month, we wanted to stop and... Read More